Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis
Author(s) -
Frank M. Brunkhorst,
Christoph Engel,
Frank Bloos,
Andreas MeierHellmann,
Max Ragaller,
Norbert Weiler,
Onnen Moerer,
Matthias Gruendling,
Michael Oppert,
Stefan Grond,
D Olthoff,
Ulrich Jaschinski,
Stefan John,
Rolf Rossaint,
Tobias Welte,
Martin Schaefer,
Peter Kern,
Evelyn Kuhnt,
Michael Kiehntopf,
Christiane S. Hartog,
Charles Natanson,
Markus Loeffler,
Konrad Reinhart
Publication year - 2008
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa070716
Subject(s) - medicine , resuscitation , sepsis , septic shock , intensive care medicine , insulin , shock (circulatory) , surviving sepsis campaign , intensive care , severe sepsis , anesthesia
The role of intensive insulin therapy in patients with severe sepsis is uncertain. Fluid resuscitation improves survival among patients with septic shock, but evidence is lacking to support the choice of either crystalloids or colloids.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom